In a world where mental agility is key to success, memory supplements are emerging as a powerful tool for enhancing cognitive performance. From students tackling rigorous academic challenges to ...

Global Glaucoma Therapeutics Market Poised for Growth; Set to Reach US$7.2 Billion by 2030 Glaucoma Therapeutics Market ...

Zhaoke Ophthalmology Ltd. (HK:6622) has released an update. Zhaoke Ophthalmology Ltd. has secured marketing authorizations ...

The National Agency for Food and Drug Administration and Control (NAFDAC) has taken significant steps in 2024 to safeguard public ...

The National Pharmaceutical Pricing Authority (NPPA) approved an increase in the price of 11 formulations of eight drugs to ...

Anti-seizure medications, which are also called anticonvulsants or anti-epileptic drugs (AEDs), are medications used to prevent seizures for people who have epilepsy. All AEDs are available only by ...

NurExone Biologic Inc. (TSXV: NRX), (OTCQB: NRXBF), (Germany: J90) ("NurExone" or the "Company"), a biopharmaceutical company ...

Several obesity experts said perhaps 20% of patients — as many as 1 in 5 — may not respond well to the medications.

Launch of Travoprost ophthalmic solution USP, 0.004 per cent adds to the company's portfolio of prescription ophthalmic products, said Glenmark Pharmaceuticals Senior Vice President, Jim Brown. Image ...

Glenmark Pharmaceuticals launches a generic glaucoma treatment, Travoprost ophthalmic solution, bioequivalent to Travatan Z. The launch expands Glenmark's ophthalmic product portfolio. New Delhi, Nov ...

Neurofibromatosis type 1 (NF1) is a rare autosomal dominant disorder that affects the skin, eyes and peripheral nervous system. It is rarely associated with glaucoma, especially in pediatric patients.

The bill is modeled after a Louisiana law that doctors say has created chaos for other gynecological issues best treated by these drugs. Boxes of mifepristone, the first pill given in a medical ...